UC Davis Comprehensive Cancer Center University of California at Davis Sacramento, California
The University of California Davis Cancer Center (UCDCC) was founded in 1991 and received its NCI designation in 2002. In 2011, it attained comprehensive status. The Center is a program of the UC Davis School of Medicine and Medical Center. Members of the Center include scientists and physicians drawn from UC Davis schools and colleges, including the School of Medicine, the School of Veterinary Medicine, the College of Agricultural and Environmental Sciences, the College of Biological Sciences, the College of Engineering, and the Lawrence Livermore National Laboratory (LLNL).
The Center consists of six scientific programs engaging 173 investigators. UCDCCC has increasingly provided tangible benefits to the California Central Valley communities that it serves in terms of state-of-the-art cancer care, while leveraging resources to advance basic, translational, transdisciplinary, and clinical cancer investigations. The Center’s formal alliance with LLNL continues to be a unique strength, integrating the expertise of biologists, physicists and engineers at LLNL with investigators at UCDCC. The impact of this integration is particularly evident in the Biomedical Technology Program.
The UC Davis School of Veterinary Medicine, with its affiliated hospital, is an additional unique resource at the Center. The School has a major focus on oncology research. Other research programs at the Center include molecular oncology, comparative oncology, cancer therapeutics, prostate cancer, and cancer health disparities and population science.
Patients are treated by multidisciplinary teams of surgical, medical, and radiation oncologists, among other specialists. Supportive care specialists include genetic counselors, nutritionists, and social workers. The Center’s comprehensive medical care for cancer patients is supported by experts in all medical disciplines. Treatment programs of note include prostate and bladder cancers, head and neck cancer, surgical intervention for pancreatic cancer, experimental therapies for lung cancers, pediatric cancers, and treatment of leukemia and lymphomas.
UCDCCC’s clinical trials enterprise includes participation in the Southwest Oncology Group, the Radiation Therapy Oncology Group, the Children’s Oncology Group, and the American College of Surgeons Oncology Group. UC Davis also is a leader of the California Cancer Consortium in Phase I and II clinical trials.
The Center is home to the Asian American Network for Cancer Awareness, Research, and Training. The Network researches cancer and cancer control awareness and offers cancer education to Asian American communities in major cities across the country. A second targeted outreach program is deploying novel materials for educating Native American women about breast cancer screening. Other programs support cancer patients and survivors in California’s Central Valley and northern inland counties.
* This profile was provided by the University of California Davis Comprehensive Cancer Center.